Selected Abstracts from the March Issue of the Journal of Vascular Surgery  by unknown
ABSTRACTSSelected Abstracts from the March Issue of the Journal of Vascular
Surgery*
Editors: Anton N. Sidawy and Bruce A. PerlerSize of juxtaluminal hypoechoic area in ultrasound images
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Objective: To test the hypothesis that the size of a juxtalu-
minal black (hypoechoic) area (JBA) in ultrasound images of
asymptomatic carotid artery plaques predicts future ipsi-
lateral ischemic stroke.
Methods: A JBA was deﬁned as an area of pixels with
a grayscale value <25 adjacent to the lumen without
a visible echogenic cap after image normalization. The size
of a JBA was measured in the carotid plaque images of 1121
patients with asymptomatic carotid stenosis 50% to 99% in
relation to the bulb (Asymptomatic Carotid Stenosis and
Risk of Stroke study); the patients were followed for up to 8
years.
Results: The JBA had a linear association with future stroke
rate. The area under the receiver-operating characteristic
curve was 0.816. Using Kaplan-Meier curves, the mean
annual stroke rate was 0.4% in 706 patients with a JBA <4
mm2, 1.4% in 171 patients with a JBA 4 to 8 mm2, 3.2% in
46 patients with a JBA 8 to 10 mm2, and 5% in 198 patients
with a JBA >10 mm2 (P < .001). In a Cox model with ipsi-
lateral ischemic events (amaurosis fugax, transient ischemic
attack [TIA], or stroke) as the dependent variable, the JBA
(<4 mm2, 4-8 mm2, >8 mm2) was still signiﬁcant after
adjusting for other plaque features known to be associated
with increased risk, including stenosis, grayscale median,
presence of discrete white areas without acoustic shadow-
ing indicating neovascularization, plaque area, and history
of contralateral TIA or stroke. Plaque area and grayscale
median were not signiﬁcant. Using the signiﬁcant variables
(stenosis, discrete white areas without acoustic shadowing,
JBA, and history of contralateral TIA or stroke), this model
predicted the annual risk of stroke for each patient (range,
0.1%-10.0%). The average annual stroke risk was <1% in
734 patients, 1% to 1.9% in 94 patients, 2% to 3.9% in 134
patients, 4% to 5.9% in 125 patients, and 6% to 10% in 34
patients.
Conclusions: The size of a JBA is linearly related to the
risk of stroke and can be used in risk stratiﬁcation*Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/S1078-5884(13)00114-7models. These ﬁndings need to be conﬁrmed in future
prospective studies or in the medical arm of randomized
controlled studies in the presence of optimal medical
therapy. In the meantime, the JBA may be used to select
asymptomatic patients at high stroke risk for carotid
endarterectomy and spare patients at low risk from an
unnecessary operation.The risk of carotid artery stenting compared with carotid
endarterectomy is greatest in patients treated within 7
days of symptoms
* Members of the Carotid Stenting Trialists’ Collaboration
are listed in the Acknowledgments.
Objective: Among patients with symptomatic carotid artery
stenosis, carotid artery stenting (CAS) is associated with
a higher risk of periprocedural stroke or death than carotid
endarterectomy (CEA). Uncertainty remains whether the
balance of risk changes with time since the most recent
ischemic event.
Methods: We investigated the association of time between
the qualifying ischemic event and treatment (0-7 days, 8-14
days, and >14 days) with the risk of stroke or death within
30 days after CAS or CEA in a pooled analysis of data from
individual patients randomized in the Endarterectomy vs
Angioplasty in Patients with Symptomatic Severe Carotid
Stenosis (EVA-3S) trial, the Stent-Protected Angioplasty
versus Carotid Endarterectomy (SPACE) trial, and the
International Carotid Stenting Study (ICSS). Data were
analyzed with a ﬁxed-effect binomial regression model
adjusted for source trial.
Results: Information on time of qualifying event was
available for 2839 patients. In the ﬁrst 30 days after inter-
vention, any stroke or death occurred signiﬁcantly more
often in the CAS group (110/1434 [7.7%]) compared with
the CEA group (54/1405 [3.8%]; crude risk ratio, 2.0; 95%
conﬁdence interval, 1.5-2.7). Patients undergoing CEA
within the ﬁrst 7 days of the qualifying event had the lowest
periprocedural stroke or death rate (3/106 [2.8%]). Patients
treated with CAS in the same period had a 9.4% risk of
periprocedural stroke or death (13/138; risk ratio CAS vs
CEA: 3.4; 95% conﬁdence interval, 1.01-11.8; adjusted for
age, sex, and type of qualifying event). Patients treated
between 8 and 14 days showed a periprocedural stroke or
death rate of 3.4% (7/208) and 8.1% (19/234), respectively,
for CEA and CAS. The latest treatment group had 4%
complications in the CEA group (44/1091) and 7.3% in the
CAS group (78/1062).
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appears to be greatest in patients treated within 7 days of
symptoms. Early surgery might remain most effective in
stroke prevention in patients with symptomatic carotid
artery stenosis.Technical factors are strongest predictors of postoperative
renal dysfunction after open transperitoneal juxtarenal
abdominal aortic aneurysm repair
Luc Dubois, Craig Durant, David M. Harrington, Thomas L.
Forbes, Guy DeRose, Jeremy R. Harris
Objective: Juxtarenal abdominal aortic aneurysms (AAAs)
have predominantly been repaired using an open tech-
nique. We present a series of patients with juxtarenal AAAs
and analyze multiple factors predictive of postoperative
renal dysfunction.
Methods: Between March 2000 and September 2011, all
patients in our prospectively maintained database
undergoing juxtarenal AAA repair were evaluated for
demographics, operative details, and in-hospital
outcomes. Postoperative renal dysfunction was classiﬁed
using the RIFLE (risk, injury, failure, loss, end-stage renal
disease) criteria (glomerular ﬁltration rate decrease
>25%). The relationship between perioperative factors
and postoperative renal dysfunction was explored using
both univariate and multivariate analysis (logistic
regression).
Results: Of 169 patients, 76 (45%) required clamping above
one renal artery, whereas 93 patients (55%) required
clamping above both renal arteries. Mean (standard devi-
ation) renal ischemia time was 29.2 (8.9) minutes (range,
12-65 minutes). Twenty-seven patients (16%) underwent
adjunctive renal procedures, 19 (11.3%) required left renal
vein division, and 130 (76.9%) received intraoperative
mannitol. Postoperative renal dysfunction occurred in 63
patients (37.3%), with the majority (69%) resolving during
hospital stay. Seven patients (4.1%) required postoperative
dialysis, which was permanent in two cases. Patients who
developed postoperative renal dysfunction had signiﬁcantly
longer mean renal ischemia times (34.7 [9.3] minutes vs
25.9 [6.6] minutes; P < .001), a higher rate of bilateral
suprarenal aortic clamping (68.3% vs 47.2%; P ¼ .008),
higher rates of adjunctive renal artery procedures (26.7% vs
8.8%; P ¼ .002), and higher rates of left renal vein division
(20.6% vs 5.7%; P ¼ .003). Logistic regression identiﬁed left
renal vein division, renal ischemia time, and aortic clamp
position as the strongest predictors of renal dysfunction.
The use of mannitol was seen to be protective. Overall in-
hospital mortality was 4.1% and was 9.5% among patients
with postoperative renal dysfunction.
Conclusions: Postoperative transient renal dysfunction
occurred in 37.3% of patients after open juxtarenal AAA
repair, with a low incidence of dialysis and a low rate of
permanent dysfunction. Technical factors including renalischemia time, aortic clamp position, and left renal vein
division are the strongest predictors of renal dysfunction.
The use of intraoperative mannitol was associated with
decreased postoperative renal dysfunction.The impact of endograft type on inﬂammatory response
after endovascular treatment of abdominal aortic
aneurysm
Konstantinos G. Moulakakis, Maria Alepaki, George S.
Sfyroeras, Constantine N. Antonopoulos, Triantaﬁllos G.
Giannakopoulos, John Kakisis, Petros Karakitsos, Christos D.
Liapis
Objective: To evaluate the impact of endograft type on the
inﬂammatory response after elective endovascular repair of
abdominal aortic aneurysms.
Methods: From January 2011 to November 2011, we
included 100 consecutive patients who underwent elective
abdominal aortic aneurysm endovascular repair. Thirteen
patients were excluded from the analysis: four with cancer,
three with autoimmune disease, two because of recent
infection, two who were receiving long-term anti-inﬂam-
matory medication, and two because of recent surgery.
Temperature, white blood cell count, platelet count, and
serum concentrations of cytokines (interleukin [IL]-6, IL-8,
and IL-10) were measured preoperatively, 24 hours post-
operatively, and 48 hours postoperatively. The study sample
was divided into four groups with respect to the type of
endograft used: group A, n ¼ 28 (Anaconda; Sulzer Vascu-
tek, Bad Soden, Germany); group B, n ¼ 26 (Zenith; Cook
Inc, Bloomington, Ind); group C, n ¼ 23 (Excluder; W. L.
Gore and Assoc, Flagstaff, Ariz); and group D, n ¼ 10
(Endurant; Medtronic, Minneapolis, Minn). Endograft
conﬁgurations included bifurcated grafts only.
Results: Epidemiologic characteristics, atherosclerotic risk
factors, type of anesthesia, mean blood loss during surgery,
and baseline serum levels of cytokines did not differ among
the four groups. Mean elevated temperature was more
pronounced postoperatively in group A. Serum levels of IL-6
and IL-10 were signiﬁcantly higher 24 hours and 48 hours
postoperatively compared with preoperative levels in all
groups. Patients in group C showed the smallest increase in
levels of serum IL-6 and IL-10 at 24 hours and 48 hours
postoperatively. Mean difference in cytokine levels after
aneurysm exclusion was greater for group A vs group C (P <
.01) compared with group A vs B (P < .05). No differences in
the mortality and morbidity rates were observed among the
four groups.
Conclusions: Endograft type appears to inﬂuence the
inﬂammatory response after endovascular aortic repair. The
postimplantation syndrome was apparent during the ﬁrst 24
hours and decreased afterward. Anaconda and Zenith
endografts induced a more intense inﬂammatory response.
A “milder” inﬂammatory activation was observed in
patients with an Excluder endograft. The postimplantation
Abstracts 307syndrome was not associated with perioperative adverse
clinical events showing a benign course. The possible long-
term sequelae of postimplantation syndrome require
further investigation.Predictors and outcomes of restenosis following tibial
artery endovascular interventions for critical limb ischemia
Naveed U. Saqib, Natalie Domenick, Jae S. Cho, Luke Mar-
one, Steven Leers, Michel S. Makaroun, Rabih A. Chaer
Objective: Restenosis following tibial artery endovascular
interventions (TAEIs) is thought to be benign but is not well
characterized. This study examines the consequences and
predictors of recurrent stenosis of TAEIs for critical limb
ischemia.
Methods: All TAEIs for critical limb ischemia performed
between 2004 and 2010 were retrospectively reviewed.
Restenosis was detected by noninvasive imaging and angi-
ography when indicated. Restenoses were identiﬁed and
the limb outcomes recorded. Tibial reinterventions were
performed only for persistent, worsening, or recurrent
tissue loss or rest pain with evidence of recurrence on
duplex ultrasound or hemodynamic imaging. The c2 test
and logistic regression were applied as indicated. One-year
patency rates were calculated using the Kaplan-Meier
method.
Results: A total of 235 limbs in 210 patients were treated for
critical limb ischemia (70% tissue loss, 30% rest pain).
Tissue loss included gangrene (49%) and ulcers (51%), and
involved the forefoot (80%), the heel (14%), or both (6%).
Seventy-eight percent of limbs had Trans-Atlantic InterSo-
ciety Consensus C/D lesions, with mean preoperative runoff
score of 12. Interventions were isolated tibial (45%) or
multilevel (55%) (including tibial). Mean postoperative runoff
score improved to 6.6, but restenosis occurred in 96 limbs
(41%) at amean of 4months.The 1-year primary patencywas
59% with a mean follow-up of 9 months. Restenosis pre-
sented with a persistent wound (32%), worsened wound
(42%), rest pain (16%), or no symptoms (10%). A repeat TAEI
was performed in 42 (44%), major amputation in 26 (27%),
open bypass in 20 (21%), and observation in eight (8%). The
overall amputation rate was 13%, but limb loss was signiﬁ-
cantly higher in patients with restenosis (n ¼ 26 [27%]) than
in patients with no restenosis (n¼ 5 [4%]; P< .001). Patients
with restenosis and tissue loss were more likely to have
presented with gangrene (63% vs 38%; P ¼ .0003) but had
comparable wound distribution (P ¼ NS). There was a trend
toward a higher restenosis rate in patients with renal insuf-
ﬁciency (odds ratio, 5.57; P¼.08), but this was unaffected by
diabetes, statin therapy, or smoking (P ¼ NS). The rate of
repeat intervention after the ﬁrst reintervention was 36%,
with an 87% overall limb salvage rate.
Conclusions: TAEIs can be used successfully to treat
patients with critical limb ischemia with acceptable limb
salvage rates. Special attention should be given to patients
with extensive tissue loss or gangrene because they are at
risk for early restenosis and subsequent limb loss. Strictwound and hemodynamic surveillance, wound care, and
timely reinterventions are crucial to achieve successful
outcomes in this patient population. Amputation or alter-
native revascularization options, when feasible, should be
considered in patients with restenosis and tissue loss given
the high rate of limb loss with tibial reinterventions.Exercise capacity is the strongest predictor of mortality in
patients with peripheral arterial disease
Nicholas J. Leeper, Jonathan Myers, Margaret Zhou, Kevin T.
Nead, Arshiya Syed, Yoko Kojima, Roxanne Diaz Caceres,
John P. Cooke
Objective: The objective of this study was to assess the
predictive value of clinical and exercise test variables in
patients with peripheral arterial disease (PAD).
Methods: A customized symptom-limited ramp treadmill
protocol was used to assess 725 PAD patients referred for
exercise testing at the Palo Alto Veterans Hospital between
1997 and 2011. Detailed clinical and exercise test data were
collected at baseline, and patients were followed up for
a mean of 11.3  6.3 years.
Results: During follow-up, there were 364 deaths. Baseline
exercise capacity was 7.0 2.6 metabolic equivalents (METs)
among survivors and 5.5  2.4 METs in those who died (P <
.001). Although several physiologic parameters differed
between survivors and nonsurvivors, age-adjusted Cox
regression revealed that exercise capacity was the strongest
independent predictor of death. Each additional MET ach-
ieved was associated with age-adjusted 18% and 20%
reductions in all-cause and cardiovascular mortality, respec-
tively (P < .001 for both). This variable surpassed all classical
risk factors (including smoking and history of congestive heart
failure) and all measured exercise test responses (including
symptoms and electrocardiograph abnormalities).
Conclusions: Among PAD patients, reduced exercise
capacity is the most powerful harbinger of long-term
mortality. This factor has predictive power beyond tradi-
tional risk factors and conﬁrms the critical importance of
ﬁtness in this cohort.Contemporary outcomes of vertebral artery injury: A 10-
year single-center experience
Daniel M. Alterman, Richard E. Heidel, Brian J. Daley, Oscar
H. Grandas, Scott L. Stevens, Mitchell H. Goldman, Michael
B. Freeman
Objective: Vertebral artery injury (VAI) associated with
cervical trauma is being increasingly recognized with more
aggressive screening. Disparate results from previous liter-
ature have led to uncertainty of the signiﬁcance, natural
history, and optimal therapy for VAI.
Methods: To understand the natural history and treatment
outcomes from our experience, we performed a retrospec-
tive, single-center review from a level I trauma center for
the previous 10 years of all VAI. Injuries were identiﬁed
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dent-run working database, and all radiology dictations for
the same period. All VAI were classiﬁed according to
segmental involvement, Denver grading scale, and laterality.
Analysis of associated injuries, demographics, neurologic
outcome, mortality, length of stay, treatment plan, and
follow-up imaging was also performed.
Results: Fifty-one patients with VAI were identiﬁed from
2001 to 2011 from a total of 36,942 trauma admissions
(0.13% incidence). Associated injuries were signiﬁcant with
an average New Injury Severity Score of 29.6. Penetrating
trauma occurred in 14%. Cervical spine fracture was present
in 88% with VAI. Diagnosis was obtained with computed
tomographic angiography (CTA) in 95%. Screening was
prompted by injury pattern or high-risk mechanism in all
cases. Injuries classiﬁed according to the Denver grading
scale were grade I ¼ 24%, grade II ¼ 35%, grade III ¼ 4%,
grade IV ¼ 35%, and grade V ¼ 2%. Distribution across
segments included V1 ¼ 18%, V2 ¼ 67%, V3 ¼ 31%, and
V4 ¼ 6%. Only one posterior circulation stroke was attrib-
utable to VAI. Overall mortality was 8%, with each mortality
being associated with signiﬁcant other organ injuries.
Treatment rendered for VAI was antiplatelet therapy (50%),
observation (31%), warfarin (17%), and stent (2%). There
were no signiﬁcant differences between treatment groups
on any variable with the exception of body mass index (P ¼
.047). Follow-up was obtained for 13% (n ¼ 6) of survivors.
The CTA demonstrated injury stability in four patients and
resolution in two patients. Accuracy of the administrative
trauma database was 53% compared with 96% for the
resident-run working database.
Conclusions: Neurologic sequelae attributable to VAI were
rare. Grade of VAI or vertebral artery segment did not
correlate with morbidity. We did not observe any differ-
ences in short-term outcomes between systemic anti-
coagulation and antiplatelet therapy. Of those patients seen
at follow-up, injury resolution or stability was documented
by CTA. A conservative approach with either observation or
antithrombotic therapy is suggested. If the natural history
of VAI includes a very low stroke rate, then therapies with
a lower therapeutic index, such as systemic anticoagulation,
in the severely injured trauma patient are not supported.Our search strategy urges awareness of the limitations of
administrative databases for retrospective vascular study.The signiﬁcance of cervical ribs in thoracic outlet
syndrome
Kevin Zou Chang, Kendall Likes, Kylie Davis, Jasmine Demos,
Julie Ann Freischlag
Objective: The purpose of this study was to review our
operative experience in patients with thoracic outlet
syndrome (TOS) resulting from cervical ribs causing clinical
symptoms.
Methods: This study is a retrospective review of a prospec-
tively acquired database of patients with TOS treatedwith ﬁrst
rib resection and scalenectomy with or without cervical rib
resection at the Johns Hopkins Medical Institutions.
Results: Between October 2003 and June 2011, a total of 23
cervical rib resections were performed on 20 patients, three
of whom had bilateral cervical ribs resected during separate
operations. Seven patients presented with subclavian artery
thrombosis. Three of seven patients had subclavian artery
aneurysms and underwent cervical rib resection through
a supraclavicular approach to facilitate subclavian artery
bypass. Five patients presented with an ischemic upper
extremity without thrombosis and underwent transaxillary
ﬁrst rib and cervical rib resection. Three patients presented
with subclavian vein thrombosis; two of the three patients
underwent balloon dilation 2 weeks postoperatively for
stenosis. Additionally, ﬁve patients presented with neuro-
genic TOS evidenced by pain, numbness, and weakness
without vascular compromise in the affected arm. Cervical
ribs with bony fusion to the ﬁrst rib were found in 17 of 23
cases (74%).
Conclusions: Cervical ribs causing clinical symptoms are
large and frequently fused to the ﬁrst rib, and can result in
aneurysm formation or thrombosis. In our experience, both
the cervical rib and the ﬁrst rib must be removed to relieve
arterial compression and can usually be done through
a transaxillary approach. Only patients with aneurysms
needing arterial reconstruction require resection of the
artery from a supraclavicular approach.
